Literature DB >> 17141979

Detection of head and neck squamous cell carcinoma with diffusion weighted MRI after (chemo)radiotherapy: correlation between radiologic and histopathologic findings.

Vincent Vandecaveye1, Frederik De Keyzer, Sandra Nuyts, Karen Deraedt, Piet Dirix, Pascal Hamaekers, Vincent Vander Poorten, Pierre Delaere, Robert Hermans.   

Abstract

PURPOSE: To investigate the value of diffusion weighted magnetic resonance imaging (DW-MRI) in differentiating persistent or recurrent head and neck squamous cell carcinoma (HNSCC) from nontumoral postradiotherapeutic alterations. METHODS AND MATERIALS: In 26 patients with suspicion of persistent or recurrent HNSCC, MRI of the head and neck was performed, including routine turbo spin-echo (TSE) sequences and an additional echo-planar DW-MRI sequence, using a large range of b-values (0-1000 s/mm(2)). Apparent diffusion coefficient (ADC) maps were calculated. In the suspect areas at the primary site and in the suspect lymph nodes, signal intensity was measured on the native b0 and b1000 images and ADC values were calculated for these tissues. The same was done for surrounding irradiated normal tissue. Imaging results were correlated to histopathology.
RESULTS: Signal intensity on native b0 images was significantly lower for HNSCC than for nontumoral postradiotherapeutic tissue (p < 0.0001), resulting in a sensitivity of 66.2%, specificity of 60.8%, and accuracy of 62.4%. Signal intensity on native b1000 images was significantly higher for HNSCC than for nontumoral tissue (p < 0.0001), resulting in a sensitivity of 71.6%, specificity of 71.3%, and accuracy of 71.4%. ADC values were significantly lower for HNSCC than for nontumoral tissue (p < 0.0001), resulting in a sensitivity of 94.6%, specificity of 95.9%, and accuracy of 95.5%. When compared with computed tomography, TSE-MRI and fluorodeoxyglucose-positron emission tomography, DW-MRI yielded fewer false-positive results in persistent primary site abnormalities and in persistent adenopathies, and aided in the detection of subcentimetric nodal metastases.
CONCLUSIONS: Diffusion weighted-MRI accurately differentiates persistent or recurrent HNSCC from nontumoral tissue changes after (chemo)radiotherapy.

Entities:  

Mesh:

Year:  2006        PMID: 17141979     DOI: 10.1016/j.ijrobp.2006.09.020

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  81 in total

Review 1.  Biologic imaging of head and neck cancer: the present and the future.

Authors:  A Srinivasan; S Mohan; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-22       Impact factor: 3.825

Review 2.  [Post-therapeutic imaging strategies and follow-up in head and neck malignant tumours].

Authors:  R Aschenbach; D Esser
Journal:  HNO       Date:  2010-08       Impact factor: 1.284

3.  Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response.

Authors:  Ann D King; Frankie K F Mo; Kwok-Hung Yu; David K W Yeung; Hua Zhou; Kunwar S Bhatia; Gary M K Tse; Alexander C Vlantis; Jeffrey K T Wong; Anil T Ahuja
Journal:  Eur Radiol       Date:  2010-03-23       Impact factor: 5.315

4.  Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.

Authors:  Su Berrak; Sanjeev Chawla; Sungheon Kim; Harry Quon; Eric Sherman; Laurie A Loevner; Harish Poptani
Journal:  Acad Radiol       Date:  2011-08-10       Impact factor: 3.173

Review 5.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

6.  Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma.

Authors:  Vincent Vandecaveye; Piet Dirix; Frederik De Keyzer; Katya Op de Beeck; Vincent Vander Poorten; I Roebben; Sandra Nuyts; Robert Hermans
Journal:  Eur Radiol       Date:  2010-02-24       Impact factor: 5.315

7.  Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma.

Authors:  R B J de Bondt; M C Hoeberigs; P J Nelemans; W M L L G Deserno; C Peutz-Kootstra; B Kremer; R G H Beets-Tan
Journal:  Neuroradiology       Date:  2009-01-10       Impact factor: 2.804

Review 8.  Squamous cell carcinoma of the head and neck-The role of diffusion and perfusion imaging in tumor recurrence and follow-up.

Authors:  Agnieszka Trojanowska
Journal:  Rep Pract Oncol Radiother       Date:  2011-07-19

9.  Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.

Authors:  I Hwang; S H Choi; Y-J Kim; K G Kim; A L Lee; T J Yun; J-h Kim; C-H Sohn
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

10.  Utility of the k-means clustering algorithm in differentiating apparent diffusion coefficient values of benign and malignant neck pathologies.

Authors:  A Srinivasan; C J Galbán; T D Johnson; T L Chenevert; B D Ross; S K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-10       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.